Gilgamesh Pharmaceuticals, a startup co-founded by Columbia's Dr. Dalibor Sames, was mentioned in a story about Texas approving legislation to spend $50 million in state money researching ibogaine, a powerful psychedelic that has shown promise in treating opioid addiction, traumatic brain injury and depression. Last year Gilgamesh won a $14 million grant from The National Institute on Drug Abuse (NIDA) to study an ibogaine analogue that the company said offered the same benefits without the cardiac risks of plant-derived ibogaine.
MBF Bioscience announced the commercial launch of SLICE, a revolutionary light sheet microscope that represents a paradigm shift in advanced imaging technology, invented by Columbia's Dr. Raju Tomer.
Explore highlights, milestones, and what's ahead for L2M.
Columbia University will support BATWorks through its engagement with Columbia Technology Ventures and the ClimateTech Expertise Network.
Scientists led by Dr. Samuel Sternberg at Columbia University have improved upon a natural system called CRISPR-associated transposase, or CAST. It combines elements of the fabled gene editor with enzymes known as transposases that move so-called ‘jumping genes’ in and out of the genome.
Sidereal Therapeutics, a startup spun out of Dr. Jonathan Barasch's lab, won a $250K XSeed Award. Sidereal is developing first-in-class therapeutics for acute kidney injury and iron-mediated disorders.
XL Batteries uses patented chemistry from the lab of Dr. Colin P. Nuckolls.
DarwinHealth, a startup spun out of Dr. Andrea Califano's lab, was included in Fast Company's list of the 10 most innovative biotech companies of 2025. DarwinHealth uses its VIPER algorithm to take experimentally measurable data from a patient’s tumor, such as gene expression profiles, and make predictions about which existing drugs are most likely to be effective against the “Tumor CheckPoint” proteins driving their particular type of cancer.
As a Columbia Startup Fellow, Diandian Zhao is transforming industrial waste into sustainable cement.
Dr. Tingting Yang will present, "Best drugs for Best disease: small molecule drugs for the treatment of best vitelliform macular dystrophy."
Dr. Haiqiu Yang received third place in the 2025 SPIE Startup Challenge, a pitch competition championing photonics innovation in healthcare and deep tech. Her company, OptiCardio, is commercializing technology from Dr. Christine Hendon's lab at Columbia.
Ioannis (John) Kymissis, W. Ian Lipkin, and Konstantin Petrukhin will be inducted as NAI Fellows at the NAI 14th Annual Meeting on June 26, 2025, in Atlanta, Georgia.